Yüklüyor......
LGG-12. SAFETY AND EFFICACY OF DUAL THERAPY WITH DABRAFENIB AND TRAMETINIB IN AN INFANT WITH BRAF V600E MUTANT INOPERABLE LOW GRADE GLIOMA
OBJECTIVE: To describe safety and efficacy of dual targeted therapy with dabrafenib (BRAFi) and trametinib (MEKi) in an infant with inoperable low grade glioma with BRAF V600E mutation. INTRODUCTION: Safety and efficacy of dual targeted therapy with BRAFi and MEKi for pediatric low grade glioma (pLG...
Kaydedildi:
| Yayımlandı: | Neuro Oncol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8168189/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noab090.136 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|